• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于评估局部晚期原发性直肠癌女性患者预后的新型盆腔廓清术分类:来自中国盆腔廓清协作组的一项回顾性队列研究

A novel classification of posterior pelvic exenteration to assess prognosis in female patients with locally advanced primary rectal cancer: a retrospective cohort study from China PelvEx collaborative.

作者信息

Li Yuegang, Zhuang Meng, Hu Gang, Zhang Jinzhu, Qiu Wenlong, Mei Shiwen, Tang Jianqiang

机构信息

Department of Colorectal Surgery, National Clinical Research Center for Cancer/Cancer Hospital, National Cancer Center, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.

出版信息

Int J Colorectal Dis. 2024 Apr 26;39(1):59. doi: 10.1007/s00384-024-04632-9.

DOI:10.1007/s00384-024-04632-9
PMID:38664256
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11045567/
Abstract

PURPOSE

Surgical techniques and the prognosis of posterior pelvic exenteration for locally advanced primary rectal cancer in female patients pose challenges that need to be addressed. Therefore, we investigated the short-term and survival outcomes of posterior pelvic exenteration in female patients using a novel Peking classification.

METHODS

We retrospectively analysed a prospective database from China PelvEx Collaborative across three tertiary referral centres. A total of 172 patients who underwent combined resection for locally advanced primary rectal cancer were classified based on four subtypes (PPE-I [64/172], PPE-II [68/172], PPE-III [21/172], and PPE-IV [19/172]) according to the Peking classification; perioperative characteristics and short-term and oncological outcomes were analysed.

RESULTS

Differences were significant among the four groups regarding colorectal reconstruction (p < 0.001), perineal reconstruction (p < 0.001), in-hospital complications (p < 0.05), and urinary retention (p < 0.05). The R resection rates for PPE-I, PPE-II, PPE-III, and PPE-IV were 90.6%, 89.7%, 90.5%, and 89.5%, respectively. The 5-year overall survival rates of the PPE-I, PPE-II, PPE-III, and PPE-IV groups were 73.4%, 68.8%, 54.7%, and 37.3%, respectively. Correspondingly, their 5-year disease-free survival rates were 76.0%, 62.5%, 57.7%, and 43.1%, respectively. Notably, the PPE-IV group demonstrated the lowest 5-year overall survival rate (p < 0.001) and 5-year disease-free survival rate (p < 0.001).

CONCLUSION

The Peking classification can aid in determining suitable surgical techniques and conducting prognostic assessments in female patients with locally advanced primary rectal cancer.

摘要

目的

女性局部晚期原发性直肠癌的盆腔后脏器切除术的手术技术和预后存在需要解决的挑战。因此,我们使用一种新的北京分类法研究了女性患者盆腔后脏器切除术的短期和生存结果。

方法

我们回顾性分析了来自中国盆腔脏器联合协作组的三个三级转诊中心的前瞻性数据库。根据北京分类法,将总共172例行局部晚期原发性直肠癌联合切除术的患者分为四种亚型(PPE-I [64/172]、PPE-II [68/172]、PPE-III [21/172]和PPE-IV [19/172]);分析围手术期特征以及短期和肿瘤学结果。

结果

四组在结直肠重建(p < 0.001)、会阴重建(p < 0.001)、住院并发症(p < 0.05)和尿潴留(p < 0.05)方面存在显著差异。PPE-I、PPE-II、PPE-III和PPE-IV的R切除率分别为90.6%、89.7%、90.5%和89.5%。PPE-I、PPE-II、PPE-III和PPE-IV组的5年总生存率分别为73.4%、68.8%、54.7%和37.3%。相应地,它们的5年无病生存率分别为76.0%、62.5%、57.7%和43.1%。值得注意的是,PPE-IV组的5年总生存率(p < 0.001)和5年无病生存率(p < 0.001)最低。

结论

北京分类法有助于确定适合的手术技术,并对女性局部晚期原发性直肠癌患者进行预后评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d75/11045567/15edf9291c68/384_2024_4632_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d75/11045567/9a4019748a98/384_2024_4632_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d75/11045567/4f5e44c30cc3/384_2024_4632_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d75/11045567/3885edb5da4c/384_2024_4632_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d75/11045567/23cdeae01336/384_2024_4632_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d75/11045567/15edf9291c68/384_2024_4632_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d75/11045567/9a4019748a98/384_2024_4632_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d75/11045567/4f5e44c30cc3/384_2024_4632_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d75/11045567/3885edb5da4c/384_2024_4632_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d75/11045567/23cdeae01336/384_2024_4632_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d75/11045567/15edf9291c68/384_2024_4632_Fig5_HTML.jpg

相似文献

1
A novel classification of posterior pelvic exenteration to assess prognosis in female patients with locally advanced primary rectal cancer: a retrospective cohort study from China PelvEx collaborative.一种用于评估局部晚期原发性直肠癌女性患者预后的新型盆腔廓清术分类:来自中国盆腔廓清协作组的一项回顾性队列研究
Int J Colorectal Dis. 2024 Apr 26;39(1):59. doi: 10.1007/s00384-024-04632-9.
2
Laparoscopic posterior pelvic exenteration is safe and feasible for locally advanced primary rectal cancer in female patients: a comparative study from China PelvEx collaborative.腹腔镜盆腔后切除术治疗女性局部晚期原发性直肠癌的安全性和可行性:中国 PelvEx 协作组的一项对比研究。
Tech Coloproctol. 2023 Nov;27(11):1109-1117. doi: 10.1007/s10151-023-02824-z. Epub 2023 May 27.
3
Posterior pelvic exenteration for primary rectal cancer.原发性直肠癌的后盆腔脏器清除术。
Colorectal Dis. 2006 May;8(4):309-13. doi: 10.1111/j.1463-1318.2005.00938.x.
4
Outcomes Following Pelvic Exenteration for Locally Recurrent Rectal Cancer With and Without En Bloc Sacrectomy.盆腔廓清术治疗局部复发性直肠癌伴或不伴整块骶骨切除术的结果。
Dis Colon Rectum. 2024 Jun 1;67(6):796-804. doi: 10.1097/DCR.0000000000003154. Epub 2024 Feb 23.
5
Outcomes of pelvic exenteration for recurrent and primary locally advanced rectal cancer.盆腔廓清术治疗复发性和原发性局部晚期直肠癌的结果。
Int J Surg. 2017 Dec;48:69-73. doi: 10.1016/j.ijsu.2017.09.069. Epub 2017 Oct 5.
6
[Analysis on risk factors of the degree of radical resection and prognosis of patients with locally recurrent rectal cancer].[局部复发性直肠癌患者根治性切除程度及预后的危险因素分析]
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 May 25;23(5):472-479. doi: 10.3760/cma.j.cn.441530-20200207-00042.
7
Short- and long-term outcomes of laparoscopic versus open pelvic exenteration for locally advanced rectal cancer: a single-center propensity score matching analysis.腹腔镜与开腹盆腔廓清术治疗局部进展期直肠癌的短期和长期疗效:单中心倾向评分匹配分析。
Tech Coloproctol. 2023 Jan;27(1):43-52. doi: 10.1007/s10151-022-02691-0. Epub 2022 Oct 4.
8
Does radiotherapy of the primary rectal cancer affect prognosis after pelvic exenteration for recurrent rectal cancer?原发性直肠癌的放疗对复发性直肠癌盆腔脏器清除术后的预后有影响吗?
Dis Colon Rectum. 2015 Jan;58(1):65-73. doi: 10.1097/DCR.0000000000000213.
9
Contemporary results from the PelvEx collaborative: improvements in surgical outcomes for locally advanced and recurrent rectal cancer.佩尔弗克斯协作组的当代研究结果:局部晚期和复发性直肠癌手术结果的改善。
Colorectal Dis. 2024 May;26(5):926-931. doi: 10.1111/codi.16948. Epub 2024 Apr 2.
10
Surgical and Survival Outcomes Following Pelvic Exenteration for Locally Advanced Primary Rectal Cancer: Results From an International Collaboration.局部晚期原发性直肠癌盆腔廓清术后的手术和生存结果:来自国际合作的结果。
Ann Surg. 2019 Feb;269(2):315-321. doi: 10.1097/SLA.0000000000002528.

本文引用的文献

1
Posterior pelvic exenteration for ovarian cancer: surgical and oncological outcomes.卵巢癌的盆腔后切除术:手术和肿瘤学结果。
J Gynecol Oncol. 2022 May;33(3):e31. doi: 10.3802/jgo.2022.33.e31. Epub 2022 Feb 4.
2
Minimally invasive versus open pelvic exenterations for rectal cancer: a comparative analysis of perioperative and 3-year oncological outcomes.微创与开放盆腔廓清术治疗直肠癌:围手术期和 3 年肿瘤学结局的比较分析。
BJS Open. 2021 Sep 6;5(5). doi: 10.1093/bjsopen/zrab074.
3
Primary pelvic exenteration: Our experience with 23 patients from a single institution.
原发性盆腔脏器清除术:我们在一家机构对23例患者的经验。
Exp Ther Med. 2021 Oct;22(4):1060. doi: 10.3892/etm.2021.10494. Epub 2021 Jul 26.
4
Laparoscopic Posterior Pelvic Exenteration (Complete and Supralevator) for Locally Advanced Adenocarcinoma of the Rectum in Females: Surgical Technique and Short-Term Outcomes.女性局部晚期直肠癌的腹腔镜后盆腔脏器清扫术(根治性和高位清扫):手术技术及短期疗效
J Laparoendosc Adv Surg Tech A. 2020 May;30(5):558-563. doi: 10.1089/lap.2019.0691. Epub 2019 Nov 27.
5
Systematic review of outcomes following pelvic exenteration for the treatment of primary and recurrent locally advanced rectal cancer.系统评价盆腔廓清术治疗原发性和复发性局部晚期直肠癌的疗效。
Tech Coloproctol. 2018 Nov;22(11):835-845. doi: 10.1007/s10151-018-1883-1. Epub 2018 Dec 1.
6
Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.直肠癌:欧洲肿瘤内科学会临床实践指南之诊断、治疗及随访
Ann Oncol. 2018 Oct 1;29(Suppl 4):iv263. doi: 10.1093/annonc/mdy161.
7
Surgical and Survival Outcomes Following Pelvic Exenteration for Locally Advanced Primary Rectal Cancer: Results From an International Collaboration.局部晚期原发性直肠癌盆腔廓清术后的手术和生存结果:来自国际合作的结果。
Ann Surg. 2019 Feb;269(2):315-321. doi: 10.1097/SLA.0000000000002528.
8
The Evolution of Pelvic Exenteration Practice at a Single Center: Lessons Learned from over 500 Cases.单一中心盆腔脏器清除术的实践演变:从500多例病例中吸取的经验教训。
Dis Colon Rectum. 2017 Jun;60(6):627-635. doi: 10.1097/DCR.0000000000000825.
9
Individualizing surgical treatment based on tumour response following neoadjuvant therapy in T4 primary rectal cancer.基于新辅助治疗后肿瘤反应对T4期原发性直肠癌进行个体化手术治疗。
Eur J Surg Oncol. 2017 Jan;43(1):92-99. doi: 10.1016/j.ejso.2016.09.004. Epub 2016 Sep 17.
10
Outcomes of Pelvic Exenteration with en Bloc Partial or Complete Pubic Bone Excision for Locally Advanced Primary or Recurrent Pelvic Cancer.局部晚期原发性或复发性盆腔癌行整块部分或全耻骨切除盆腔廓清术的疗效
Dis Colon Rectum. 2016 Sep;59(9):831-5. doi: 10.1097/DCR.0000000000000656.